Which Patient Benefits from Guideline-directed Medical Therapy for Heart Failure and Rate Control versus Rhythm Control in Patients with Congestive Heart Failure and Atrial Fibrillation and What are Those Therapies?

Q: What is the clinical evidence from this study?

Study design: Review. Population: Heart Failure and Atrial Fibrillation. Intervention: Rhythm control (catheter ablation and antiarrhythmic drugs) vs. Rate control.

Gregory Burkman; Gerald V Naccarelli

doi:10.15420/aer.2025.39

May 4, 2026Arrhythmia & Electrophysiology ReviewOpen Access

Which Patient Benefits from Guideline-directed Medical Therapy for Heart Failure and Rate Control versus Rhythm Control in Patients with Congestive Heart Failure and Atrial Fibrillation and What are Those Therapies?

View Full Paper

Ask AI

Bookmark

Share

Figures

Why the study?

The management of AF in patients with heart failure is complex and nuanced.

Key Points

To determine which patients with heart failure benefit from guideline-directed medical therapy for atrial fibrillation and the specific therapies used.
Explored antiarrhythmic effects of various medical therapies
Reviewed pharmacological and ablative treatments for atrial fibrillation
Differentiated recommendations for heart failure with reduced vs. preserved ejection fraction
Guideline-directed therapies shown to have distinct benefits for different heart failure subtypes
Ablative treatments proposed as effective for specific patient groups
Pharmacological intervention strategies highlighted for heart failure management

Structured PICO

P

Population

Patients with congestive heart failure and atrial fibrillation

I

Intervention

Guideline-directed medical therapy, pharmacological and ablative treatments for AF (rate versus rhythm control)

Limitations

The definition and inclusion of patients with HFpEF in studies remain varied
Further clarity and standardization of the diagnosis and causes of HFpEF are needed

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

This review outlines the complex management of atrial fibrillation in patients with heart failure, providing treatment recommendations tailored to HFrEF and HFpEF subtypes.

Abstract

The management of AF in patients with heart failure is complex and nuanced. This paper explores the potential antiarrhythmic effects of guideline-directed medical therapy for heart failure and reviews the pharmacological and ablative treatments for AF. Heart failure with reduced ejection fraction is discussed separately from heart failure with preserved ejection fraction. Treatment recommendations for each heart failure subtype are given.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Burkman et al. (2026) conducted a review in Heart Failure and Atrial Fibrillation. Rhythm control (catheter ablation and antiarrhythmic drugs) vs. Rate control was evaluated.

synapsesocial.com/papers/6a11f7b092637892a9a5a599 https://doi.org/10.15420/aer.2025.39

View Full Paper

Ask AI

Bookmark

Share

Which Patient Benefits from Guideline-directed Medical Therapy for Heart Failure and Rate Control versus Rhythm Control in Patients with Congestive Heart Failure and Atrial Fibrillation and What are Those Therapies?

Figures

Key Points

Structured PICO

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Which Patient Benefits from Guideline-directed Medical Therapy for Heart Failure and Rate Control versus Rhythm Control in Patients with Congestive Heart Failure and Atrial Fibrillation and What are Those Therapies?

Figures

Key Points

Structured PICO

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading